Don’t miss Laura Davidson, MD, for her session, “Innovation at NYV: Orthotopic Transcatheter Tricuspid Valve Replacement.” Cardiovascular Research Foundation #NYValves2024. See the full schedule here: nyvalves2024.crfconferences.com/program-guide?…

🗓️Date: ᴀᴘʀɪʟ 17-19, 2025 🗓️ 🌍ʀɪʏᴀᴅʜ - ꜱᴀᴜᴅɪ ᴀʀᴀʙɪᴀ 🌍 Cardiovascular Research Foundation TCT Conference Juan F. Granada MIЯVΛƬ #IC Wail AlkashkariFSCAI,FPICSوائل القشقرى🇸🇦🇨🇦🇺🇲 Khaled AlShaibi Dr.Khalid Al Faraidyالدكتور خالد الفرائضي Mamas A. Mamas

Please follow our new social media account TCTME+ for all the latest news and exciting developments of TCT Middle East

Well deserved tribute to a giant whose innovative spirit and kindness will stay with us forever!

🚀 Introducing Cusper, a novel transcatheter device for #AR. Designed to fill regurgitant orifice of #AV, it merges an artificial cusp w/native valve to prevent backflow into LV during diastole. #NYValves2024 📊 👉tctmd.com/slide/transcat… Yair Feld #innovationWithPurpose Guido Ascione

🚨 This #JACCINT analysis of the PRIME-MR registry demonstrated the prognostic implication ☠️ of residual MR, not #MVG, in those with primary #MR undergoing #TEER! bit.ly/3xU686U #vhdMR Augustin Coisne

🌟 Is this the future of #TV regurgitation treatment? 🔍 Meet TriFlO, a unique device featuring 3 anchors positioned at the #TV commissures and polymer leaflets to adapt to irregular shape orifices. #NYValves2024 📊 👉 tctmd.com/slide/percutan… #InnovationWithPurpose Guido Ascione

🌟 #TEER is the gold standard for MR but has limitations. Enter Tioga: a novel #TMVR approach w/unique anchoring mechanism and adaptable valve prosthesis. Explore the #NYValves2024 presentation from Azeem Latib 📊👉 tctmd.com/slide/tioga-no… #InnovationWithPurpose Guido Ascione

Day 1 of #TCTPlusIndia2024 is in the books! ✅ There are still 2 more days of this comprehensive course featuring world-renowned faculty. 🌏 Don’t miss out on the opportunity to experience the future of interventional cardiovascular medicine! 🚀 tctplusindia2024.in #CardioX

✨#NYValves2024 showcased 2 intriguing AI-powered innovations for #structuralheart imaging: 🚀Robotically assisted imaging solution for CV interventions Edwin Ho 🚀Robotic TEE system for diagnostics and interventional guidance Jury #InnovationWithPurpose Guido Ascione

📈Dive into the full #NYValves 2024 presentations here: 🔗 Laza Medical: tctmd.com/slide/ai-power… 🔗ROB’E: tctmd.com/slide/first-hu… #InnovationWithPurpose #CardioX Guido Ascione

💡 Curious about solutions for severe, symptomatic #TR? Discover the Laplace #TTVR system! Designed for procedural simplicity & adaptability, it tackles diverse pathologies. 🔍 #NYValves2024 early data Thomas Waggoner 📊 👉 tctmd.com/slide/early-fe… #InnovationWithPurpose Guido Ascione

🔍 #TEER is a great first-line therapy, but complex anatomies often yield suboptimal outcomes. The Half Moon leaflet augmentation device may offer more predictable performance. 🌟 Pilot study #NYValves2024 Azeem Latib 📊 👉tctmd.com/slide/early-hu… #innovationWithPurpose Guido Ascione

🌟 Introducing the MonarQ System for #TTVR 🏥 Designed for both transfemoral & transjugular delivery, it targets patients w/symptomatic, severe TR at high surgical risk. Early data at #NYValves2024 shows promise. 📊 👉 tctmd.com/slide/monarq-s… #InnovationWithPurpose Guido Ascione

✨ #TCT2024 is just two months away! From data-driven breakthroughs to the latest technological advances, your front-row seat to the future of cardiovascular medicine awaits. 🚀 Don’t miss the most exciting meeting of the year, where innovation and patient care converge. Secure

#TCT2024 Late-Breaking Research Announced! 🚨 🌟 The moment you’ve been waiting for is here! Discover game-changing research that will revolutionize cardiovascular care. Get ready to witness the breakthroughs that will transform your practice and redefine patient outcomes. 🚀

🔍 Is this the future of #TMVR? Discover ValSync, an implant that adjusts w/saline-filled balloons to fit each patient’s unique valvular anatomy. Explore the design and data behind this innovation at #NYValves2024 📊 👉 tctmd.com/slide/anatomic… #InnovationWithPurpose Guido Ascione

CRF announces late-breaking clinical trials for #TCT2024 Cardiovascular Research Foundation ow.ly/ThSU50T8I7U

🚀 Experience Innovation in Action! 🌟 Dive into the latest global innovations with a full-access or Sunday one-day pass at the #TCT2024 MedTech Innovation Forum. 🔗 Learn more and secure your pass: tct2024.crfconferences.com/tct-medtech-in… #innovation #medtech #CardioX #CardioTwitter

💡 Simple may be best for #TTVR in patients with severe #TR. Trillium is a streamlined solution with a shorter implantation time and no echo guidance or general anesthesia needed. 🏥 #NYValves2024 📊 👉 tctmd.com/slide/heteroto… Philipp Lurz #InnovationWithPurpose Guido Ascione